Understanding the complications of antiretroviral drugs

Clin Infect Dis. 2008 Aug 15;47(4):575-6. doi: 10.1086/590155.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / classification
  • Anti-HIV Agents / pharmacology
  • Endothelium, Vascular / drug effects
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / classification
  • HIV Protease Inhibitors / pharmacology
  • HIV Seronegativity*
  • Humans
  • Insulin Resistance
  • Vasodilation / drug effects

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors